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A B S T R A C T
Phytochemical investigation of the methanol extracts of the twigs ofManniophyton fulvum has led to the isolation
and characterization of three new pentacyclic triterpenoids, designated as 3α,28-dihydroxyfriedelan-1-one (1),
manniotaraxerol A (3) and manniotaraxerol B (4), along with fourteen known compounds, 3α-hydroxy-1-oxo-
friedelane (2), betulinic acid (5), friedelin (S1), taraxerol (S2), a mixture of stigmasterol (S3) and β-sitosterol
(S4), herranone (S5), docosanoic acid (S6), ursolic acid (S7), nasutin B (S8), bergenin (S9), stigmasterol-3-O-β-D-
glucopyranoside (S10), 1,2-di-O-palmitoyl-3-O-(6-sulfo-α-D-quinovopyranosyl)glycerol (S11), and aridanin
(S12). The structures of all compounds were determined by comprehensive spectroscopic analyses (1D and 2D
NMR, EI and ESI-MS). 3α,28-Dihydroxyfriedelan-1-one (1), 3α-hydroxy-1-oxofriedelane (2), manniotaraxerol A
(3), manniotaraxerol B (4), and betulinic acid (5) were evaluated against HeLa (human cervix adenocarcinoma)
cancer cells. Manniotaraxerol A (3) showed weak in vitro cytotoxicity with a cell viability value of 49.3%.
Betulinic acid (5) also showed signiﬁcant cytotoxicity against HeLa cell with a cell viability value of 4.0%; the
other compounds were inactive in this test.
1. Introduction
Manniophyton fulvum Johannes Müller Argoviensis (synonym
Manniophyton wildemanii Beille), belongs to the family of
Euphorbiaceae, consisting of shrubs or climbers of about 30m height;
the stem is cylindrical, up to 12 cm in diameter (Brink and Achigan-
Dako, 2012). M. fulvum is distributed widely in tropical Africa from
Sierra Leone to Sudan as well as southwards to Angola. In African
traditional medicine, the stem, leaf, root and bark are used against
diarrhea, stomach ache, cough, bronchitis, oxidative stress, and in-
ﬂammation (Nia et al., 2005). This plant has also been used as remedy
for dysentery, hemorrhoids, hemoptysis and dysmenorrhea, and also to
heal wounds. The red stem sap possesses haemostatic activities, while
the leaf sap is used against ear problems and teeth ache (Ojieh et al.,
2013; Brink and Achigan-Dako, 2012; Piba et al., 2015). Interestingly,
extracts of this plant exhibited potent antidiarrheal, antioxidant anti-
inﬂammatory and aphrodisiac activities (Ojieh et al., 2013; Gbesso
et al., 2016; Nia et al., 2005). The bark ﬁber is strong and durable,
making it sought-after by ﬁshermen and hunters for the production of
nets. The phytochemical screening of the leaves ofManniophyton fulvum
showed the presence of alkaloids, saponins, phenols, tannins, ﬂavo-
noids, cardiac glycosides, steroids, phytosterols, triterpenoids and
phlobatannins (Agbaire et al., 2013; Ojieh et al., 2013); there is no
report dealing with the isolation and characterization of these meta-
bolites from the title plant. From the twigs of this plant, we have mostly
isolated triterpenes, which are generally endowed with anti-cancer
properties (Chudzik et al., 2015); this motivated us to perform also
cytotoxic tests.
In this paper, we report the isolation and structural elucidation of
three new pentacyclic triterpenoids named 3α,28-dihydroxyfriedelan-
1-one (1), manniotaraxerol A (3), and manniotaraxerol B (4), together
with the 13C NMR assignments of 3α-hydroxy-1-oxofriedelane (2) as
well as the cytotoxicity of 1–3 and betulinic acid (5) against HeLa
(human cervix adenocarcinoma) cells.
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2. Results and discussion
The methanol extract of the twigs of M. fulvum was concentrated
under vacuum and then separated by column chromatography on silica
gel to aﬀord three new pentacyclic triterpenoids and fourteen known
metabolites.
The known compounds were identiﬁed by comparison of experi-
mental and reported spectroscopic data as 3α-hydroxy-1-oxofriedelane
(2) (Thao et al., 2010; Tewari et al., 1974), betulinic acid (5) (Yili et al.,
2009), friedelin (S1) (Ragasa et al., 2015), taraxerol (S2) (Sakurai et al.,
1987), stigmasterol (S3) (Chaturvedula and Prakash, 2012), β-sitosterol
(S4) (Chaturvedula and Prakash, 2012), herranone (S5) (Wiedemann
et al., 1999), docosanoic acid (S6), ursolic acid (S7) (Seebacher et al.,
2003), nasutin B (S8) (Khac et al., 1990), bergenin (S9) (Zhong et al.,
1984), stigmasterol-3-O-β-D-glucopyranoside (S10) (Mahbuba et al.,
2012), 1,2-di-O-palmitoyl-3-O-(6-sulfo-α-D-quinovopyranosyl)glycerol
(S11) (Amarquaye et al., 1994), and aridanin (S12) (Feumo et al.,
2016) (Fig. 1, supplementary information). The new triterpenoids were
identiﬁed by comprehensive spectroscopic analyses.
3α,28-Dihydroxyfriedelan-1-one (1) was obtained as a white
powder. The molecular composition was determined as C30H50O3 by
(+)-ESI HRMS. Its IR spectrum exhibited bands for carbonyl (1685
cm−1) and hydroxy functionalities (3341 cm−1).
The 13C NMR, HSQC and HMBC spectra indicated the presence of
seven methyls, eleven methylenes, ﬁve methines and seven quaternary
carbons, among them a ketone group at δC 210.7. According to the
number of carbon atoms and six double bond equivalents, a pentacyclic
saturated triterpene with a ketone group was assumed. The presence of
signals due to one secondary and six quaternary methyls in the 1HNMR
spectrum suggested a friedelane skeleton (Mahato and Kundu, 1994)
(Table 2). A cross correlation in the COSY spectrum between a methyl
doublet at δH 1.24 (H-23) and a methine quartet at δH 1.86 (H-4)
conﬁrmed the presence of a secondary methyl group as previously re-
ported for other friedelanes (Mahato and Kundu, 1994).
The presence of a primary and secondary hydroxy group in com-
pound 1 (Fig. 1) was evident from the 1H NMR spectrum (Table 2),
Fig. 1. Chemical structure of compounds. 1-5.
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which showed the AB signal of an oxymethylene group at δH 3.90/3.96
and of an oxymethine multiplet at δH 4.42. The oxymethine group was
located at C-3 by the aid of HMBC spectrum, which exhibited correla-
tion between the 1H multiplet at δH 4.42 and C-1, C-2, and C-5. Three-
bond couplings between protons at δH 3.90 and 3.96, respectively, with
the methylene carbons C-16, C-22, with the quaternary carbon C-17 and
with the methine carbon C-18 indicated a C-28 hydroxylation and
thereby explained the missing of one methyl group. Furthermore, the
protons H2-2, H-3, and H-10 displayed HMBC correlations with the
carbonyl signal and veriﬁed the position of the ketone at C-1 (Fig. 2).
This was conﬁrmed by the HMBC correlations between H2-2 (δH 2.78,
2.91) and C-1, 3, 4 and C-10, and a COSY correlation with H-3. This and
further 2D NMR correlations (see Table 2) together with literature data
conﬁrmed a new 3α,28-dihydroxyfriedelan-1-one.
The relative conﬁguration of 1 was assigned by interpretation of the
nuclear Overhauser eﬀect spectra (NOESY), which showed cross peaks
between H-3 (δH 4.42) and H-23 (δH 1.24), so that with the usual 28β-
methyl group of friedlanes, a 3α-hydroxy group was expected (Fig. 4).
From 13C NMR, HMBC and HSQC experiments, all carbons and protons
were unambiguously assigned (Table 2). It should be stated that also
the extreme low-ﬁeld shift of the methine group C-10 (δC 71.8, δH 2.41)
was conﬁrmed by the carbonyl at C-1. Thus, the structure of compound
1 was assigned as 3α,28-dihydroxyfriedelan-1-one.
The known 3α-hydroxy-1-oxofriedelane (2) was obtained as a col-
orless powder. It diﬀers from compound 1 by C-28, where a methyl
group instead of the hydroxymethylene group was found. Compound 2
was initially isolated from the root-bark of Salacia prenoides DC (Tewari
et al., 1974), and further obtained from Camellia japonica (Thao et al.,
2010) with no report of NMR data. This is the ﬁrst report of 1H and 13C
NMR data of 2 (Fig. 1, Table 2).
Manniotaraxerol A (3) was obtained as a colorless powder. The
molecular composition was determined as C30H50O2 by (+)-ESI HRMS,
suggesting a further triterpenoid structure with six double bond
equivalents. The IR spectrum showed absorption bands for hydroxy
(3370 cm−1) and trisubstituted double bond functionalities (1372
cm−1).
The 13C spectrum of 3 showed characteristic signals of the tarax-
erene skeleton at δC 159.1 and 117.5 for C-14 and C-15 (Wiedemann
et al., 1999; Mahato and Kundu, 1994). The 13C NMR and HSQC spectra
displayed eight methyls, nine methylenes, six methines (two of them
were oxymethines) and seven quaternary carbons (Table 3). The ole-
ﬁnic proton H-15 of a trisubstituted double bond (dd at δH 5.70)
showed HMBC correlations with C-8, C-13, C-16 and C-17. Further
HMBC correlations were observed between the oxymethine proton H-1
at δ 3.69 with C-9 and C-25; H-3 coupled with C-4 and C-24; H-2 gave
cross signals with C-1, C-3, C-4, and C-10 (Fig. 3). COSY correlations
were also observed between the methylene protons H-2 with the oxy-
methine proton H-1 (δH 3.69) and H-3 (δH 3.59) and between the ole-
ﬁnic proton H-15 and protons H-16.
According to spectroscopic data, compound 3 (Fig. 1) has the same
skeleton as taraxer-14-ene-1α,3β-diol (Li et al., 2009); the NOESY
spectrum showed, however, that the relative conﬁguration of 3 at C-1 is
diﬀerent. In fact, the NOESY correlation of H-1 (δH 3.69) with H-5 (δH
0.84) indicated that H-1 and H-5 are on the same side in α positions
(Fig. 4). From the above spectroscopic data, the structure of compound
3 was elucidated as taraxer-14-ene-1β,3β-diol and named
Fig. 2. Signiﬁcant HMBC and COSY correlations of 3α,28-dihydroxyfriedelan-1-one (1), and 3α-hydroxy-1-oxofriedelane (2).
Fig. 3. Signiﬁcant HMBC and COSY correlations of manniotaraxerol A (3), and manniotaraxerol B (4).
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manniotaraxerol A.
Compound 4 was isolated as amorphous powder with the molecular
formula C30H50O3 by (+)-ESI HRMS. The IR spectrum showed ab-
sorption bands for hydroxy groups (3307 cm−1) and double bonds
(1466 cm−1). Compared to compound 3, compound 4 has one oxygen
atom more. Its 1H NMR spectrum (Table 3) showed signals of seven
quaternary methyl groups instead of eight as in compound 3. These
data suggested a pentacyclic triterpene as well. The 1H and 13C NMR
spectra of 4 (Fig. 1) were surprisingly similar to those of 3, except for
the presence of a further hydroxymethylene group in 4 instead of the
methyl group C-28 in 3, which was conﬁrmed by the HMBC correla-
tions of H-28 with C-16 and C-22 (Fig. 3). The relative conﬁguration of
4 was assigned through interpretation of the NOESY correlations as well
as coupling constant values. The large coupling constant of H-1 in 4
J=10.6 Hz suggested that the hydroxy group is in β-orientation
(Fig. 4). This assumption was further supported by the NOESY spectra,
Fig. 4. Signiﬁcant NOESY correlations of 3α,28-dihydroxyfriedelan-1-one (1), manniotaraxerol A (3), and manniotaraxerol B (4).
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which showed correlations of H-1 to H-9, H-3 to H-9, H-1 to H-3 and H-
3 to H-5, indicating the β-orientation of hydroxy groups at C-1 and C-3.
Further 2D NMR experiments allowed the determination of compound
4 as taraxer-14-ene-1β,3β-28-triol, which we named manniotaraxerol
B.
The absolute conﬁguration of compounds 1–4 was determined by
comparison of experimental and ab initio-calculated CD spectra, as de-
scribed previously (Naureen et al., 2017). The results (see Fig. 5) con-
ﬁrmed the stereo structures as shown in the formulas.
3α,28-Dihydroxyfriedelan-1-one (1), 3α-hydroxy-1-oxofriedelane
(2), manniotaraxerol A (3), manniotaraxerol B (4) and betulinic acid
(5) were evaluated against HeLa (human cervix adenocarcinoma)
cancer cells. Table 1 shows the result of the viability test.
The new compound manniotaraxerol A (3) showed low in vitro cy-
totoxicity against HeLa cancer cells with a cell viability value of 49.3%
at 62.5 μg/ml. The cytotoxicity of betulinic acid (5) against HeLa cells
(viability 4.0%) (Desai et al., 2008) was conﬁrmed. The other new
compounds were inactive in this test, and we found instead that com-
pound 4 increased the growth of these cells slightly.
3. Experimental
3.1. General
Optical rotation was measured on a Perkin-Elmer polarimeter,
model 241, at the sodium D line (l= 589 nm). UV/VIS spectra were
recorded on a JASCO V-650 spectrometer (JASCO Labor und
Datentechnik Deutschland GmbH, Gross-Umstadt, Germany). IR spectra
were taken on a Jasco FT/IR-4100 type A instrument. The NMR spectra
were recorded on a Varian Inova-500 NMR spectrometer at
300.141MHz (1H) and 125.8MHz (13C), respectively. Chemical shifts
are given as δ values in ppm with tetramethylsilane (TMS) as internal
standard, and coupling constants are given in Hertz (Hz). ESIHR mass
spectra (MS) were obtained on a Bruker micrOTOF mass spectrometer.
Open column chromatography was performed on silica gel (60–200
mesh). Thin layer chromatography (TLC) was carried out on pre-coated
silica gel 60F254 plates (Merck), and the TLC spots were visualized
under UV light at 254 nm or by spraying with 20% sulfuric acid fol-
lowed by heating.
4. Plant material
The twigs of M. fulvum were collected on November 25, 2015 in the
south of Cameroon, in the Loukounje district near Ndoumale. The
material was identiﬁed by the botanist Victor Nana, National
Herbarium of Cameroon, Yaounde, where a voucher specimen (ref.
44496HNC) has been deposited.
5. Extraction and isolation
The air-dried and powdered twigs (7.1 kg) of M. fulvum were ex-
tracted with methanol at room temperature for 72 h. Evaporation under
reduced pressure resulted in 60.2 g of crude extract. A part (56.2 g) of
this extract was chromatographed over silica gel (70–230mesh) with a
stepwise n-hexane-EtOAc gradient (39:1, 19:1, 9:1, 17:3, 4:1, 3:1, 3:2,
1:4) and EtOAc. Elution with n-hexane-EtOAc (39:1) delivered doc-
osanoic acid (S6, 16.4mg; 0.03%; Rf = 0.44, n-hexane-EtOAc 50:1),
friedelin (S1, 11.2mg; 0.02%; Rf = 0.66, n-hexane-EtOAc 39:1), and
taraxerol (S2, 4.1 mg; 0.007%; Rf = 0.29, n-hexane-EtOAc 37:3).
Elution with n-hexane-EtOAc (19:1), gave a mixture of stigmasterol
(S3) and β-sitosterol (S4, 19.3 mg; 0.03%; Rf = 0.61, n-hexane-EtOAc
37:3), herranone (S5, 3.2 mg; 0.006%; Rf = 0.27, n-hexane-EtOAc 9:1),
and 3α-hydroxy-1-oxofriedelane (2, 10.1mg; 0.02%; Rf = 0.21, n-
hexane-EtOAc 9:1); elution with n-hexane-EtOAc (9:1) aﬀorded betu-
linic acid (5, 13.2 mg; 0.02%; Rf = 0.23, n-hexane-EtOAc 9:1) and ur-
solic acid (S7, 7.0 mg; 0.01%; Rf = 0.27, n-hexane-EtOAc 9:1). 3α,28-
Dihydroxyfriedelan-1-one (1, 4.2 mg; 0.007%; Rf = 0.74, n-hexane-
EtOAc 7:1) and manniotaraxerol A (3, 8.1 mg; 0.01%; Rf = 0.28, n-
hexane-EtOAc 7:1) were obtained by elution with n-hexane-EtOAc
(17:3). By elution with n-hexane-EtOAc (4:1), nasutin B (S8, 2.1 mg;
0.004%; Rf = 0.37, n-hexane-EtOAc 7:1), and with n-hexane-EtOAc
(3:1) manniotaraxerol B (4, 48.0 mg; 0.09%; Rf = 0.33, n-hexane-
EtOAc 15:7) were obtained. Bergenin (S9, 4.1 mg; 0.007%; Rf = 0.51,
EtOAc) and stigmasterol-3-O-β-D-glucopyranoside (S10, 38.3 mg;
0.07%; Rf = 0.33, CH2Cl2-MeOH 7:1) were isolated by elution with n-
hexane-EtOAc (3:2). Finally, 1,2-di-O-palmitoyl-3-O-(6-sulfo-α-D-qui-
novopyranosyl)glycerol (S11, 3.1 mg; 0.006%; Rf = 0.41, EtOAc-MeOH
37:3) and aridanin (S12, 2.1 mg; 0.004%; Rf = 0.47, CH2Cl2-MeOH 9:1)
were eluted with EtOAc.
6. Cytotoxic activity
HeLa (human cervix adenocarcinoma) cells were maintained in
Dulbecco's Modiﬁed Eagle’s Medium (DMEM) with 5mM L-glutamine
(Lonza), supplemented with 10% fetal bovine serum (FBS) and anti-
biotics (penicillin/streptomycin/fungizone - PSF) for 24 h. To assess the
overt cytotoxicity of the extracts, the cells were incubated in 96-well
plates at a concentration of 62.5 μg/mL with the compounds 1-5. The
number of cells surviving drug exposure were counted using the re-
sazurin based reagent and resoruﬁn ﬂuorescence quantiﬁed
(λExcitation= 560/λEmission= 590 nm) in a multiwell plate reader.
Table 1
Cytotoxicity of compounds 1-5 against HeLa cells at 62.5 μg/ml.
Compounds Percental HeLa cell viability
3α,28-Dihydroxyfriedelan-1-one (1) 87.5
3α-Hydroxy-1-oxofriedelane (2) 97.1
Manniotaraxerol A (3) 49.3
Manniotaraxerol B (4) 110.3
Betulinic acid (5)
Emetine
4.0
3.08
Fig. 5. 3α,28-dihydroxyfriedelan-1-one (1), 3α-hydroxy-1-oxofriedelane (2),
manniotaraxerol A (3), and manniotaraxerol B (4).
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(Mbosso et al., 2017). The results are listed in Table 1.
6.1. α,28-Dihydroxyfriedelan-1-one (1)
Colourless glistening needles, m.p. 286 °C; UV/Vis (MeOH): λmax (lg
ε)= 202 (2.92), 280 nm (2.05). CD spectrum (MeOH) see Fig. 5. IR
(ﬁlm): νmax 3341, 2933, 2866, 1685, 1460; 1383, 1216, 1144, 1042,
1009, 755 cm−1; 1H and 13C NMR data, see Table 2; (+)-ESI HRMS m/
z=459.3833 [M+H]+, (calcd for C30H51O3 459.3833)
6.2. α-Hydroxy-1-oxofriedelane (2)
Colorless powder, m.p. 280 °C; CD spectrum (CHCl3) see Fig. 5. 1H
and 13C NMR data, see Table 2 and Supplement Figs. 12 and 13.
6.3. Manniotaraxerol A (3)
Colorless powder, m.p. 282 °C; UV/Vis (MeOH): λmax (lg ε)= 207
(3.85), 275 nm (2.53). CD spectrum (MeOH) see Fig. 5. IR (neat): νmax
3370, 3182, 2×938, 2866, 1463, 1372, 1308, 1098, 1047, 1003, 816
cm−1; 1H and 13C NMR data, see Table 3; (+)-ESI HRMS m/z 443.3877
[M+H]+, (calcd for C30H51O2 443.3881)
6.4. Manniotaraxerol B (4)
Colorless powder, m.p. 267 °C; UV/Vis (MeOH): λmax (lg ε)= 207
(3.80), 275 nm (2.58). CD spectrum (MeOH) see Fig. 5. IR (ﬁlm): νmax
3307, 2973, 2941, 1466, 1437, 1080, 1000, 690 cm−1; 1H and 13C
NMR data, see Table 3; (+)-ESI HRMS m/z 459.3833 [M+H]+, (calcd
for C30H51O3 459.3833)
Table 2
1H (600MHz) and 13C (125MHz) NMR data of 3α,28-dihydroxyfriedelan-1-one (1) and 3α-hydroxy-1-oxofriedelane (2) in pyridine-d5 a; coupling constants were
measured in [Hz].
1 2
δC δH HMBC δC δH HMBC
Cq-1 210.7 – – 210.7 – –
CH2-2 54.2 2.91 ddd (13.2, 5.4, 1.2) 1,3,4,10 54.2 2.90 ddd (13.9; 5.0; 1.3) 1,3
2.78 dd (13.2, 1.9) 1,3,4,10 2.79 dd (13.5;2.3) 1,3,4,10
CH-3 75.6 4.42 brs 1,5 75.6 4.42 m nc
CH-4 50.1 1.86 m 5,23,24 50.1 1.86 m nc
Cq-5 44.6 – – 44.6 – –
CH2-6 42.9 1.80 dt (12.4; 3.0) 5,8,10,24 42.9 1.80 dt (12.5; 3.2) nc
1.27 m nc 1.27 m 7,24
CH2-7 18.5 1.44 m nc 18.5 1.44 m
CH-8 52.5 1.33 m 9,14,26 53.0 1.28
Cq-9 37.6 – – 37.5 – –
CH-10 71.8 2.41 s 1,4,5,8,9,11,24,25 71.8 2.39 s 1,4,5,8,9,
11,24,25
CH2-11 35.4 2.30 dt (13.3; 3.3) 12,13 35.5 2.28 dt (14.0; 3.5) nc
1.28 m 1.25 m nc
CH2-12 30.8 1.47 m nc 31.1 1.42 m nc
1.36 m 13 1.27 m 9,14
Cq-13 40.2 – – 40.5 – –
Cq-14 39.0 – – 39.0 – –
CH2-15 32.3 1.49-1.55 m 17 33.0 1.47 m nc
1.38 m 17 1.28 m nc
CH2-16 30.5 2.36 m 14,15,17,18,28 36.9 1.58 m nc
1.44-1.51 m 14,15,17,28 1.36 m nc
Cq-17 36.4 – – 30.7 – –
CH-18 40.3 1.54 m 17,20,28 43.7 1.57 m 12,13,17,19,27,28
CH2-19 35.5 1.54 m 17,18,20 36.1 1.40 m nc
1.38 m 17,18,20 1.24 m nc
Cq-20 28.9 – – 28.9 – –
CH2-21 34.4 1.75 td (14.0; 4.2) 20,22 33.8 1.50 m nc
1.35, 1.38 2m nc 1.29 m nc
CH2-22 33.0 1.85-1.90 m 18,20 40.0 1.51 m nc
1.54 m – 0.94 m 17,18,20
CH3-23 12.6 1.24 d (7.0) 3,4,5 12.6 1.25 d (7.0) 3,4,5
CH3-24 18.7 1.31 s 4,5,6,10 18.7 1.34 s 4,5,6,10
CH3-25 19.5 1.51 s 8,9,10,11 19.3 1.51 s 8,9,10,11
CH3-26 19.7 1.04 s 8,13,14,15 20.9 1.02 s 8,13,14,15
CH3-27 20.2 1.19 s 12,13,14,18 19.5 1.04 s 12,13,14,18
CH2/3-28 68.1 3.96 d (10.6) 16,17,22 32.8 1.20 s 16,17,18,22
3.90 d (10.6) 16,17,18,22 – –
CH3-29 34.9 1.06 s 19,20,21,30 35.6 0.99 s 19,20,21,30
CH3-30 33.7 1.07 s 19,20,21,29 32.6 1.06 s 19,20,21,29
nc: no correlation; a pyridine-d5 as standard with δC= 123.87; δH=7.22 ppm.
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